Suppr超能文献

多巴胺能功能与精神病性抑郁症患者对地塞米松的皮质醇反应

Dopaminergic function and the cortisol response to dexamethasone in psychotic depression.

作者信息

Duval F, Mokrani M C, Crocq M A, Bailey P E, Diep T S, Correa H, Macher J P

机构信息

Centre Hospitalier, Rouffach, France.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Feb;24(2):207-25. doi: 10.1016/s0278-5846(99)00098-6.

Abstract
  1. It has been hypothesized that psychotic symptoms in depression may be due to increased dopamine activity secondary to hypothalamic-pituitary-adrenal (HPA) axis overactivity. 2. To test this hypothesis, the authors examined the cortisol response to dexamethasone suppression test (DST, 1 mg orally) and multihormonal responses to apomorphine (APO, 0.75 mg s.c.)--a dopamine agonist--in 150 drug-free hospitalized patients with DSM-IV major depressive episode with psychotic features (MDEP, n=35), major depressive episode without psychotic features (MDE, n=74), or schizophrenia paranoid type (SCZ, n=41), and 27 hospitalized healthy controls (HCs). 3. MDEPs showed increased activity of the HPA system (i.e. higher post-DST cortisol levels) than HCs, SCZs and MDEs. However, there were no differences in adrenocorticotropic hormone (ACTH), cortisol, prolactin and growth hormone (GH) responses to APO between MDEPs and MDEs and HCs. On the other hand, SCZs showed lower APO-induced ACTH stimulation and a higher rate of blunted GH than HCs, MDEs and MDEPs, suggesting a functional alteration of the hypothalamic dopamine receptors in SCZs. 4. In the total sample and in each diagnostic group, DST suppressors and non-suppressors showed no differences in hormonal responses to APO. 5. These results suggest a lack of causal link between HPA axis hyperactivity and dopamine dysregulation. In contrast to schizophrenia, psychotic symptoms in depression seem not to be related to dopamine function dysregulation.
摘要
  1. 有一种假说认为,抑郁症中的精神病性症状可能是由于下丘脑 - 垂体 - 肾上腺(HPA)轴过度活跃继发多巴胺活性增加所致。2. 为了验证这一假说,作者检测了150名未服用药物的住院患者对地塞米松抑制试验(DST,口服1毫克)的皮质醇反应以及对阿扑吗啡(APO,皮下注射0.75毫克)——一种多巴胺激动剂——的多激素反应。这些患者包括患有DSM - IV 伴有精神病性特征的重度抑郁发作(MDEP,n = 35)、不伴有精神病性特征的重度抑郁发作(MDE,n = 74)或偏执型精神分裂症(SCZ,n = 41),以及27名住院健康对照者(HCs)。3. MDEP患者的HPA系统活性高于HCs、SCZs和MDE患者(即DST后皮质醇水平更高)。然而,MDEP患者与MDE患者及HCs之间在促肾上腺皮质激素(ACTH)、皮质醇、催乳素和生长激素(GH)对APO的反应上并无差异。另一方面,与HCs、MDE患者和MDEP患者相比,SCZ患者的APO诱导的ACTH刺激较低,GH钝化率较高,这表明SCZ患者下丘脑多巴胺受体存在功能改变。4. 在总样本以及每个诊断组中,DST抑制者和非抑制者在对APO的激素反应上没有差异。5. 这些结果表明HPA轴亢进与多巴胺失调之间缺乏因果联系。与精神分裂症不同,抑郁症中的精神病性症状似乎与多巴胺功能失调无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验